drugset
drugset / Trial / NCT06649110

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 ↗

Phase 1/2 Recruiting 232 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)

Timeline

Start
2024-10-24
Primary completion
2028-11-29
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject LTP001 Unknown — —

Indications

pulmonary arterial hypertension